PanGen Biotech Inc (222110) - Total Liabilities

Latest as of September 2025: ₩2.74 Billion KRW ≈ $1.86 Million USD

Based on the latest financial reports, PanGen Biotech Inc (222110) has total liabilities worth ₩2.74 Billion KRW (≈ $1.86 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

PanGen Biotech Inc - Total Liabilities Trend (2014–2024)

This chart illustrates how PanGen Biotech Inc's total liabilities have evolved over time, based on quarterly financial data. See working capital position of PanGen Biotech Inc to evaluate short-term liquidity relative to the company's equity base.

PanGen Biotech Inc Competitors by Total Liabilities

The table below lists competitors of PanGen Biotech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Red Pine Exploration Inc V:RPX	Canada	CA$1.55 Million
JSS Real Estate SOCIMI SA MC:YJSS	Spain	€291.53 Million
Asian Pac Holdings Bhd KLSE:4057	Malaysia	RM1.12 Billion
Bever Holding NV AS:BEVER	Netherlands	€13.49 Million
Entain PLC LSE:ENT	UK	GBX8.04 Billion
Emami Realty Limited NSE:EMAMIREAL	India	Rs23.96 Billion
MClean Technologies Bhd KLSE:0167	Malaysia	RM34.49 Million
OS Therapies Incorporated NYSE MKT:OSTX	USA	$4.25 Million

Liability Composition Analysis (2014–2024)

This chart breaks down PanGen Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is PanGen Biotech Inc worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.52	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.09	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.08	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how PanGen Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for PanGen Biotech Inc (2014–2024)

The table below shows the annual total liabilities of PanGen Biotech Inc from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩5.64 Billion ≈ $3.82 Million	-31.06%
2023-12-31	₩8.18 Billion ≈ $5.54 Million	+136.67%
2022-12-31	₩3.45 Billion ≈ $2.34 Million	-84.43%
2021-12-31	₩22.18 Billion ≈ $15.03 Million	+0.37%
2020-12-31	₩22.10 Billion ≈ $14.98 Million	+6.98%
2019-12-31	₩20.66 Billion ≈ $14.00 Million	+10.65%
2018-12-31	₩18.67 Billion ≈ $12.65 Million	+335.84%
2017-12-31	₩4.28 Billion ≈ $2.90 Million	+104.76%
2016-12-31	₩2.09 Billion ≈ $1.42 Million	-77.60%
2015-12-31	₩9.34 Billion ≈ $6.33 Million	+50.99%
2014-12-31	₩6.18 Billion ≈ $4.19 Million	--

About PanGen Biotech Inc

KQ:222110 Korea Biotechnology

Market Cap

$42.98 Million

₩63.42 Billion KRW

Market Cap Rank

#22524 Global

#1433 in Korea

Share Price

₩4700.00

Change (1 day)

-2.39%

52-Week Range

₩4510.00 - ₩7340.00

All Time High

₩24450.00